Search the Newsreel

Aquestive Prepares FDA Resubmission for Severe Allergy Treatment Following Successful Study

Aquestive Therapeutics (AQST) announced positive results from human factors and pharmacokinetic validation studies for its Anaphylm sublingual film, a severe allergy treatment. These studies address prior FDA feedback, demonstrating significant improvements in product usability and effective drug delivery even with slight misplacement. The company …

Aquestive Therapeutics (NASDAQ:AQST) Shares Gap Up - Should You Buy?

Earnings To Watch: Aquestive Therapeutics Inc (AQST) Q2 2026 -- GF Value Sees 35% Downside

Aquestive Therapeutics Inc (AQST) is preparing to release its Q2 2026 earnings on August 11, 2026, with revenue expected at $11.42 million and earnings at $-0.12 per share. While analysts predict a significant upside of 125.61% based on average price targets, GuruFocus's GF Value …

Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm Sublingual Film

Aquestive Therapeutics has announced positive topline results from its human factors and pharmacokinetic studies for Anaphylm™ (dibutepinephrine) sublingual film. These results support the planned resubmission of its New Drug Application (NDA) to the FDA in Q3 2026, addressing previous issues with packaging and administration. …

Queen’s Road Capital Investment Ltd. (TSX:QRC) Stock Falls 3.07% as Resource Market Volatility and Investment Portfolio Risks Pressure Sentiment

Aquestive Therapeutics releases Anaphylm human factors, clinical study presentation materials

Aquestive Therapeutics has released supplemental materials on human factors and clinical results for its Anaphylm (dibutepinephrine) sublingual film program. A resubmission human factors study showed fewer use issues compared to the original NDA study, with a median open time reduced to 3 seconds. A …

Aquestive Reports Positive Human Factors and PK Results for Anaphylm, Plans NDA Resubmission Q3 2026

Aquestive announced positive human factors and pharmacokinetic (PK) results for Anaphylm, indicating significant improvements in usability and comparable drug delivery. These results support the planned New Drug Application (NDA) resubmission in Q3 2026 for the epinephrine treatment. The study showed reduced errors in self-administration …

AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Aquestive Therapeutics, Inc. (NASDAQ: AQST) and its officers. The lawsuit, filed on behalf of investors who purchased securities between June 16, 2025, and January 8, 2026, alleges that the company made false …

Frequency Electronics Inc (FEIM) Earnings Forecast: Future EPS & Revenue Growth Estimates

Bronstein, Gewirtz & Grossman, LLC Is Investigating Aquestive Therapeutics, Inc. (AQST) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aquestive Therapeutics, Inc. (AQST) who bought securities prior to June 16, 2025, and still hold them. The investigation aims to determine if Aquestive officers engaged in corporate wrongdoing. The firm …

IVY LANE CAPITAL MANAGEMENT, LLC's Quest Diagnostics Inc(DGX) Holding History

This article details IVY LANE CAPITAL MANAGEMENT, LLC's historical holdings in Quest Diagnostics Inc (DGX). As of March 31, 2026, the firm holds 29,000 shares valued at $5.68 million, representing 8.59% of its portfolio. The investment has generated an estimated gain of $4.19 million, …

Alice Queen (ASX:AQX): Why Is Horn Island Back in Focus?

Alice Queen Mobilises Drill Rig for Multi-Phase Campaign at Horn Island Gold Project

How Investors May Respond To Quebecor (TSX:QBR.A) Earnings Beat, Buyback Renewal And Dividend Confirmation

Quest Resource Holding Corp (QRHC) Stock News Today

This article provides a brief update on Quest Resource Holding Corp (QRHC) stock news, earnings, analyst ratings, and key developments. It notes that more news is expected soon and provides current stock performance data, showing a recent increase of 18.11%. The page serves as …

Quest Resource Holding Corp (QRHC) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Quest Resource Holding Corp (QRHC), highlighting its current earnings forecast score, average price target of $3.00, and analyst ratings. Based on 2 analysts, the stock has a "Buy" trend. Key financial expectations include an anticipated revenue of …

Quest Diagnostics Incorporated (QDI.F) Stock Price, News, Quote & History

Daily Brief Australia: Rio Tinto , EBOS Group , Academies Australasia, Adcorp Australia, AdVeritas , Airtasker, Alice Queen Ltd, Aldoro Resources Ltd, Alterity Therapeutics , Accelerate Resources Ltd and more

Quebecor (TSX:QBR.A) Stock Faces Debt Questions After Profit Margin Jump

Quest Diagnostics Inc (DGX) Stock News Today

This article from TradingKey provides a news page for Quest Diagnostics Inc (DGX) stock. It includes current stock performance metrics like price, market cap, and P/E ratio. The page indicates that more news will be coming soon regarding DGX stock.

Quest Resource (NASDAQ:QRHC) Posts Better-Than-Expected Sales In Q2 CY2026

Quest Resource Holding Corporation Reports Second Quarter 2026 Financial Results

Quest Resource Holding Corporation (QRHC) reported a 7.6% increase in Q2 2026 revenue to $64.1 million, driven by new customer wins and wallet share expansions. Despite a GAAP net loss of $(12.2) million due to a non-cash goodwill impairment, Adjusted EBITDA grew to $2.8 …

Frequency Electronics Inc (FEIM) Stock News Today

The Bull Case For Quest Diagnostics (DGX) Could Change Following Raised Guidance And New Self-Collection Services

Quest Resource Holding Corporation Q2 2026 Earnings Call Summary

Bronstein, Gewirtz & Grossman, LLC Encourages Aquestive Therapeutics, Inc. (AQST) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aquestive Therapeutics, Inc. (NASDAQ:AQST) securities. The investigation focuses on whether Aquestive officers and/or directors engaged in corporate wrongdoing, particularly for investors who purchased shares before June 16, 2025, and still …

Quest Diagnostics Incorporated $DGX Holdings Trimmed by Empowered Funds LLC

Empowered Funds LLC significantly reduced its stake in Quest Diagnostics (NYSE:DGX) by 61.5% in the first quarter, selling over 15,000 shares. Despite this, institutional investors still own a substantial 88.06% of the company's stock. Quest Diagnostics exceeded Q1 earnings and revenue expectations, and analysts …

Quebecor Class A Shares Marked Down Nearly 5% After Q2 Beat — Blame the Trading, Not the Business

Quest Resource Holding Corp Q2 2026: Revenue $64.07M, EPS $(0.57) — 10-Q Summary

Quest Resource Holding Corp (QRHC) reported its second-quarter 2026 results, showing a revenue increase to $64.07 million, up 7.6% year-over-year. Despite the revenue growth, the company recorded a net loss of $12.22 million and a diluted loss per share of $(0.57), primarily due to …

Goodwill write-down deepens loss at Quest Resource (NASDAQ: QRHC) in Q2 2026

Sei Investments Co. Has $4.06 Million Stock Position in Frequency Electronics, Inc. $FEIM

Sei Investments Co. significantly increased its stake in Frequency Electronics, Inc. (FEIM) by 93.1% in the first quarter, now holding 91,706 shares valued at approximately $4.06 million. Despite FEIM trading near its 12-month high, the company missed analyst expectations for quarterly earnings and revenue. …

HireQuest, Inc. (HQI) Q1 2023 Earnings Report - Results, Call & Slides

HireQuest, Inc. (HQI) reported its Q1 2023 earnings, missing consensus EPS estimates with an actual EPS of $0.19 against an expected $0.28. However, the company beat revenue expectations, achieving $9.86M against a projected $9.62M, marking a 21.02% year-over-year revenue growth. The earnings call was …

QRHC Q2 Deep Dive: Revenue Growth and Portfolio Diversification Offset Margin Pressure

Quebecor Earnings: Net Addition and Revenue Per User Growth Drive Constructive Results

Quest Resource Holding Corp (QRHC) (Q2 2026) Earnings Call Highlights: Returns to Growth with ...

Quest Resource Holding Corp (QRHC) reported a return to revenue and adjusted EBITDA growth in Q2 2026, with revenue up 8% year-over-year. The company diversified its client base, reduced SG&A by 11%, and generated strong operating cash flow of $4.5 million, contributing to debt …

Quest Resource Holding posts Q2 2026 revenue up 7.6% to $64.1M; Adjusted EBITDA $2.8M

Quest Resource Holding reported a 7.6% year-over-year increase in Q2 2026 revenue, reaching $64.1 million, with an Adjusted EBITDA of $2.8 million. Despite a GAAP net loss of $(12.2) million due to an $11.0 million goodwill impairment, the company achieved $4.5 million in operating …